Viewed: 1244
Emailed: 0
PDF Downloaded: 351
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 2, Issue : 2, Year : 2016
Article Page : 109-111
Abstract
Background: Efficient treatment of iron deficiency anaemia in pregnant women would lead to a considerable reduction in the risk factors, affecting maternal and fetal outcome.
Patients and Methods: This prospective study was carried out in 84 women between 20 to 34 weeks of pregnancy with established iron deficiency anaemia and haemoglobin 6-10g/dL. They were randomised to receive either oral or intravenous iron in required dose. Haemoglobin and ferritin levels were measured at recruitment and after 4 weeks of therapy. Adverse drug reactions were also noted in both the groups. Results were analysed by student’s t-test.
Results: The mean increase in haemoglobin values with IV sucrose group was 1.26 ±0.58g % as compared to 0.78 ±0.37 gm% in oral iron group after 4 weeks of oral iron therapy (p<0.03). Similarly, The mean increase in ferritin values with IV sucrose group was 12.00 ± 11.77ng/ml as compared to 6.50 ± 9.53ng/ml in oral iron group (p<0.02).
Conclusion: This study indicates iron sucrose not only treats but also corrects iron stores which are not seen with oral iron.
Keywords: Iron deficiency anaemia, Iron sucrose, Oral iron therapy
How to cite : Agarwal N, Sharma A, Gupta M, Agrawal A, Efficacy and safety of intravenous iron sucrose versus oral iron in pregnant women with mild to moderate iron deficiency anaemia. Santosh Univ J Health Sci 2016;2(2):109-111
Copyright © 2016 by author(s) and Santosh Univ J Health Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)